INTRODUCTION
Cancer cells rely on altered gene expression programmes to achieve optimal conditions for proliferation and survival and maintain their malignant phenotype (Califano and Alvarez, 2017) . Previous studies suggested that small sets of transcription factors (TFs) can act together to form core-regulatory circuits (CRCs) that critically influence a cell's transcriptomic state (Boyer et al., 2005) . These TFs collectively control each other's gene expression to form highly inter-connected autoregulatory loops (Odom et al., 2004 (Odom et al., , 2006 Saint-André et al., 2016) . Changes in the regulation of CRC TFs can result in an altered gene expression state that can promote disease Sanda et al., 2012) . Therefore, it is important to identify CRCs and study their regulation to better understand disease mechanisms and find potential routes for novel therapeutic intervention.
While much progress has been made to define the CRCs for a number of cell types (Boyer et al., 2005; van Groningen et al., 2017; Saint-André et al., 2016; Sanda et al., 2012) , the composition of CRCs across different cancer types and how they are regulated to promote tumorigenesis remains poorly understood. This is in part due to substantial experimental efforts that are required for the identification and validation of CRCs. Previous approaches have primarily employed ChIP-seq experiments to map the binding sites of TF genes in close proximity to super enhancer (SE) regions (Parker et al., 2013; Whyte et al., 2013) . A recent study has shown that MYCN-amplified neuroblastoma cells crucially depend on the TFs that constitute their CRC for cell growth and survival (Durbin et al., 2018) .
Additionally, we and others have previously observed selective dependencies of other cancer cell types on TFs that play a role in development and differentiation of their associated tissues (Cheung et al., 2011; Kim et al., 2018; Rauscher et al., 2018) . This indicated that CRC composition could critically influence selective gene dependencies in cancer cells of various tumor lineages.
Here, we examined whether we could systematically predict the CRCs of different cancer types from gene essentiality data. To this end, we analyzed genome-scale CRISPR fitness screens (Shalem et al., 2014; Wang et al., 2014) in 558 cancer cell lines (Meyers et al., 2017) for gene dependencies specific to a cancer's tissue of origin (henceforth referred to as 'lineage'). Among these, we found a strong enrichment for TF genes, many of which had previously been described to be part of the CRCs of certain cell types. Where available, public ChIP-seq and super enhancer data confirmed that these TF can regulate each other's activity and are associated with super enhancer elements. We queried large-scale cancer genome databases (Cancer Genome Atlas Research Network et al., 2013; Forbes et al., 2017) and found that predicted CRC TFs are frequently affected by somatic alterations.
Previous studies have demonstrated that functionally related genes (e.g. members of the same protein complex or pathway) show highly correlated essentiality profiles across cell lines (Pan et al., 2018) . We employed this strategy to group all lineage dependency genes into functional units and link them to predicted CRCs. This revealed biological processes implicated in the aberrant regulation of CRCs in cancer that could represent potential points of vantage for therapeutic interventions. Finally, we explored how invading tumour cells might be able to adapt their CRCs in order to adapt to their new niche. Our analysis shows that addiction to lineage-specific core-regulatory circuits and their dysregulated state occurs across a broad range of tumor types. It provides a foundation for studying these CRCs and how they control different tumor lineages and demonstrates how CRC composition determines tissue-specific gene and pathway dependencies.
RESULTS

Context-dependent essential genes are enriched for lineage dependency transcription factors
Context-specific essential genes are genes whose knockout has little or no effect on the proliferation and survival of most cell lines, while a small number of cell lines are highly dependent on their activity. We assumed that core-regulatory circuits are composed of transcription factors that are selectively essential in the associated tumour lineages.
Therefore, we first tested whether TFs were overrepresented among all context-dependent essential genes. To this end, we identified all genes for which increased dependency -as measured in CRISPR fitness screens (Meyers et al., 2017) -was observed in a restricted set of all cancer cell lines ( Figure 1A , Figure 1B , Supplementary Figure 1A) . We then ranked all genes by the number of selectively dependent lines. The oncogenes KRAS , BRAF , NRAS and PIK3CA were among the top ranking context essential genes ( Figure 1C ). Cells with mutations in these genes are well known to become selectively dependent on them through oncogene addiction indicating that we correctly identified context-dependent essentiality (Weinstein and Joe, 2008) . Gene set enrichment analysis (Sergushichev, 2016) further revealed that TFs (Gene Ontology Consortium, 2015) were indeed overrepresented among the most context-dependent essential genes (NES = 1.45, FDR = 0.0017; Figure 1D ).
We next clustered cancer cell lines by their dependency on context essential TFs ( Figure 1E ). We found several distinct clusters of genes that showed highly specific essentiality in cell lines derived from the same tissue of origin. These findings prompted us to devise a score to quantify selective gene dependency of cancer lineages that we termed 'Lineage dependency (LD)-score'. This score quantifies lineage dependency as the difference between the average viability phenotype upon gene knockout in each individual cancer lineage compared to the overall phenotype across all cancer types ( Figure 1F ). Next, we calculated LD-scores for all TF (Lambert et al., 2018) Table 1) . To assess whether LD-scores could recapitulate known lineage-specific gene dependencies, we examined TFs with high melanoma LD-scores. As expected, we found the melanocyte master regulator MITF (Garraway et al., 2005; Levy et al., 2006) and the Wnt-signaling effector TCF7L2 Morin et al., 1997; Zhan et al., 2017) among the top scoring genes for melanoma and colorectal cancer, respectively (LD-score = 4.61, FDR = 5.40x10
-49 and LD-score = 4.37, FDR = 6.18x10 -31 ; Figure 1G ). Along with MITF the LD-score further identified other melanocyte-specific TFs known to bind the MITF promoter to regulate its gene expression, such as SOX10 (LD-score = 5.46, FDR = 3.50x10 -69 ), PAX3 (LD-score = 1.71, FDR = 9.82x10 -7 ) or ZEB2 (LD-score = 4.27, FDR = 3.22x10 -31 ) (Hartman and Czyz, 2015) . These findings suggest that context-dependent essentiality can in fact reveal transcriptional master regulators of different tumor lineages. 
LD-TFs compose cancer lineage specific core-regulatory circuits
We next investigated whether LD-TFs represent, at least in part, the CRCs of the dependent cancer lineages. Thus, we selected significant LD-TFs (LD-score > 1, FDR < 5%; 205 in total) as components of putative regulatory circuits in the associated cancer lineages (Supplementary Table 1 ). The number of LD-TFs identified for each cancer lineage was highly variable ranging from 5 (lung cancer) to 60 (myeloma; Supplementary Figure 2A ).
Clustering of cancer lineages by LD-scores revealed groups of common developmental background (Supplementary Figure 2B) . TFs acting together as CRCs are known to be highly inter-regulated (Boyer et al., 2005) and under transcriptional control of super enhancer (SE) elements . Therefore, we further annotated our putative CRCs with public TF-target-gene (Harmonizome) and super enhancer data (SEdb; Figure 2A ) (Jiang et al., 2019; Rouillard et al., 2016) .
To validate this approach, we examined whether it could recapitulate known biology.
The CRC of hepatocytes is one of the most well-studied regulatory circuits (Odom et al., 2004 (Odom et al., , 2006 . Here, the hepatocyte nuclear factors HNF1A , HNF4A and ONECUT1 ( HNF6 ) as well as FOXA2 have been described as key players regulating each other's activity to maintain the hepatocyte transcriptional state. These TFs were also part of the hepatocellular carcinoma CRC we predicted for hepatocellular carcinoma from gene essentiality data ( Figure 2B ). In addition, our predicted CRC contained additional TFs that have previously been described (El-Khairi and Vallier, 2016; Nguyen et al., 2014) to play important roles during liver development, such as HNF1B (LD-score = 3.79, FDR = 8.66x10 -7 ) or LIN28B
(LD-score = 2.29, FDR = 9.06x10 -6 ). As expected, public transcription factor databases (ENCODE Project Consortium, 2004; Lachmann et al., 2010; Matys et al., 2003; Rouillard et al., 2016; Xu et al., 2013) report a large number of TF-target gene relationships (i.e. genes can bind each other's promoters) between TFs in our predicted liver CRC (p = 6.03x10 -7 , Kolmogorov-Smirnov test; Figure 2C ). Also, the SEdb database (Jiang et al., 2019) reports a higher number of SE elements associated with these TFs compared to other transcription factors in liver samples (p = 1.73x10 -5 , two-sided Wilcoxon rank sum test; Figure 2D ). This implies that LD-TFs could in fact recapitulate lineage specific CRCs.
We next examined the putative CRC of colorectal cancer that, as such, had not previously been described. In total we found 11 TFs with significant LD-scores in colorectal cancer cell lines ( Figure 2E ). These included several genes known to play a role during the development and differentiation of colon cells (Gao et al., 2009; Silberg et al., 2000; Yu et al., 2017) such as CDX2 (LD-score = 1.56, FDR = 2.74x10 -6 ) and SATB2 (LD-score = 1.65, FDR = 1.12x10 -5 ). Some of these genes have also been shown to promote tumorigenesis when aberrantly activated; TCF7L2 , the gene with the highest colorectal cancer LD-score (LD-score = 4.37, FDR = 6.18x10 -31 ) is the effector of the Wnt signaling pathway that is mutated in the majority of colorectal cancers. Again we found that TF-target gene relationships between colorectal LD-TFs had been reported frequently in the Harmonizome database (p = 1.09x10 -7 , Kolmogorov-Smirnov test; Figure 2F ). Similarly, more SE elements linked to these TFs had been identified compared to other transcription factors in colon or colorectal cancer samples (p = 6.26x10 -7 , two-sided Wilcoxon rank sum test; Figure   2G ). Moreover, public ChIP-seq data (ENCODE Project Consortium, 2004) 
Lineage dependency transcription factors are important in both, normal and cancer tissue and can have oncogenic potential
Since CRCs inferred from LD-scores included several transcription factors that had previously been implicated in tumorigenesis and cancer progression, we asked whether LD-TFs could act as lineage survival oncogenes (Garraway and Sellers, 2006) . Lineage survival oncogenes are genes that play crucial roles during tissue development and that can be deregulated in cancer (Garraway and Sellers, 2006) . They are thought to i) play important roles in normal lineage survival during development, ii) be deregulated in cancers of the associated lineage and iii) be affected by somatic alterations in tumor subsets. To answer these questions for significant LD-TFs (LD-score > 1, FDR < 5%), we surveyed the genome databases GTEx, ExAC, TCGA and COSMIC ( Figure 3A ) (Cancer Genome Atlas Research Network et al., 2013; Forbes et al., 2017; GTEx Consortium et al., 2017; Lek et al., 2016) .
We found that damaging mutations in LD-TFs occur less frequently in living individuals compared to other transcription factors or non-TF genes (ExAC; p = 6.303x10 -10 , two-sample Student's t-test; Figure 3B , Supplementary Figure 3A ) (Lek et al., 2016) indicating that LD-TFs are subject to strong selective pressure. Further, gene expression of LD-TF genes was restricted to their associated tissues in non-cancer samples (GTEx; p = 2.2x10 -16 , two-sample Wilcoxon rank sum test, Figure 3C , Supplementary Figure 3B ) (GTEx Consortium et al., 2017) . Similarly we found higher expression of LD-TF genes in tumor transcriptomes representing the associated cancer lineage as compared to other lineages (TCGA; p < 2.2x10 -16 ; two-sample Wilcoxon rank sum test, Figure 3D , Supplementary Figure   3C ) (Cancer Genome Atlas Research Network et al., 2013) . We tested whether LD-TFs were differentially expressed in cancer compared to healthy samples and found that LD-TFs were down-regulated less frequently (p = 0.11) and up-regulated more frequently (p = 0.10) than expected by chance ( Figure 3E ). For the remaining genes, however, we did not detect a change in expression. Also, many TFs that were differentially expressed between healthy and cancer samples did not show a phenotype in CRISPR screens (Supplementary Figure   3D -E) (Barretina et al., 2012; Meyers et al., 2017) . Finally, we investigated whether LD-TFs are affected by somatic molecular alterations in tumors ( Figure 3F ) (Forbes et al., 2017 ) .
While we did not find frequent (>5% of samples corresponding to a tumor lineage) somatic variants for all LD-TFs, we identified common somatic alterations for a significant subset of LD-TFs (p = 2.235x10 -11 , Fisher's exact test). These results indicate that a subset of LD-TFs could in fact act as lineage survival oncogenes, modify CRC activity and initiate a cancer promoting gene expression program. . (E) LD-TFs (blue dot) are down-regulated less often and up-regulated more often than expected (black box; 1,000 TF random samples) in tumor samples compared to healthy reference samples (TCGA). Differential gene expression was determined using a two-sample Welch's t-test. The Benjamini-Hochberg method was used to control the false discovery rate at 20%. The center of each box is the sample median, the whiskers extend from the upper (lower) hinge to the largest (smallest) data point no further than 1.5 times the interquantile range from the upper (lower) hinge. (F) Molecular variants including somatic mutations, somatic copy number gains, hypomethylation or gene fusion occur more often than expected in LD-TFs (p = 2.627 x 10 -11 , Fisher's exact test). A gene was determined as altered in tumor type if the alteration was found in more than 5% in the COSMIC database. The heatmaps show LD-TF status (left heatmap; black indicates lineage dependency at LD-score > 1 and FDR < 5%) and molecular alteration status (right heatmap) for the top 3 LD-TF determined for each cancer type that could be mapped to the COSMIC database.
Co-dependency predicts mechanisms leading to CRC deregulation in cancer
Samples from tumors and healthy adjacent tissue represent two distinct transcriptomic states when clustered by principal component analysis (PCA) (Califano and Alvarez, 2017) . A healthy cell has to adapt its gene expression program in order to transform into a cancer cell with increased cell proliferation and survival ( Figure 4A ). This can be achieved through the deregulation of a TFs with oncogenic potential (Bradner et al., 2017) . Since oncogenic TFs are part of CRCs that control a cell's transcriptomic state, we assumed a model where the aberrant activation of a TF with transformative potential leads to CRC deregulation; either through somatic alterations in an upstream pathway or the TF itself (Alvarez et al., 2016) .
This results in an altered transcriptional output that enables cancer development ( Figure   4B ). We expected highly selective dependency on components of the CRC and upstream pathways (Supplementary Figure 4A) required to achieve its deregulation, while we assumed that cancer promoting target genes should be less lineage specific. Again, we took melanoma cells as an example to explore this hypothesis since the mechanisms of aberrant MITF activation have been carefully studied in the past (Garraway et al., 2005; Levy et al., 2006; Wellbrock and Marais, 2005; Wellbrock et al., 2008) . We first selected all genes (both TF and non-TF) with significant LD-scores in melanoma cell lines (LD-score > 1, FDR < 5%).
In total, we selected 15 TFs representing the CRC and 161 non-TF genes as putative CRC regulators and target genes. We then clustered these genes by codependency across all 558 screened cell lines to group them into functional units as described previously ( Figure   4C ) (Pan et al., 2018; Rauscher et al., 2018 BRAF is mutated in the majority of melanomas and is well known to regulate MITF to promote tumor proliferation and survival (Wellbrock et al., 2008) . In addition, we found clusters that were comprised of genes involved in processes such as epithelial-mesenchymal transition (EMT) or apoptosis ( Figure 3C ) (Cicchini et al., 2008; Mott et al., 2007) . Both of these processes are known to be dysregulated as the consequence of aberrant MITF activation ( Figure 4D ) (Denecker et al., 2014; Hartman and Czyz, 2015; Levy et al., 2006) . Encouraged by these observations we aimed to systematically link the CRCs of different tumor lineages to associated biological processes. We selected significant LD-genes for each cancer lineage and grouped them into 2-10 distinct codependency clusters (see Methods). We then performed a Gene Ontology enrichment analysis for each cluster (Alexa and Rahnenfuhrer, 2010; Gene Ontology Consortium, 2015; Ritchie et al., 2015) . In total we identified 149 clusters across 20 cancer lineages that we linked to a diverse range of biological processes (1,508 unique GO IDs, FDR < 20%; Supplementary Figure 4B , Supplementary Table S2 ). The 7 clusters selected for melanoma, for example, enriched for processes such as MAPK signaling (p=1.40x10e -4 ), melanocyte differentiation (p=1.76x10 -4 ), cell division (p=1.77x10 -3 ), or apoptosis (p=3.32x10 -4 ). As expected, specificity of dependency phenotypes (quantified by average LD-scores of genes in a cluster) was highest for CRC genes and their upstream regulators (MAPK signaling) while target processes showed weaker, although still significant, specificity ( Figure 4E ). These observations suggest that regulatory mechanisms of lineage specific CRCs can in fact be identified by examining global codependency profiles of lineage dependency genes. 
Metastatic cancer cells might alter their core-regulatory circuit to adapt to their new niche
We noticed that in many cases dependency on LD-TF could vary across cell lines representing the same cancer lineage. For example, several melanoma cell lines do not depend on the melanocyte master regulator MITF for proliferation and survival. At the same time, MITF expression is decreased in these cell lines ( Figure 5A ). Similarly, MITF resistant melanoma cell lines show decreased expression of key melanocyte differentiation markers such as MLANA , PMEL or TYR ( Figure 5B ) (Vazquez et al., 2013) . This phenomenon, termed 'phenotype switching', is not restricted to cell lines but is also observed in patient tumors (Supplementary Figure 5A) where it is associated with increased resistance to a range of therapies (Müller et al., 2014; Perotti et al., 2016) and increased invasive potential (Vachtenheim, 2017) . We hypothesized that melanoma cells might have the ability to adapt their CRC in order to achieve a gene expression state that is more favorable for invasion. To investigate this, we clustered 5,471 tumor samples (Cancer Genome Atlas Research Network et al., 2013) by their expression of significant LD-TF genes (LD-score > 1, FDR <
5%) using t-Distributed Stochastic Neighbor Embedding (t-SNE). The expression of LD-TF
genes was sufficient to achieve clustering of tumor samples by cancer type ( Figure 5C , Supplementary Figure 5B) . We noticed that, while all MITF high samples clustered together to form a melanoma-specific cluster ( Figure 5C ), many MITF low samples clustered with soft tissue sarcoma samples instead. Loss of MITF expression was associated with increased expression of the key EMT (epithelial to mesenchymal transition) activator ZEB1
(Supplementary Figure 5C -D) (Burk et al., 2008) . ZEB1 is an LD-TF in soft tissue sarcoma cells (LD-score = 1.5, FDR = 0.007) that are characterized by their mesenchymal origin. We further found that melanoma LD-TFs were differentially expressed in MITF low compared to MITF high samples ( Figure 5D ). This indicates, that MITF low cells might be able alter their CRC -potentially in order to adapt to the new environment that they invade. We further found that decreased expression of MITF was associated with the gain of new gene dependencies.
Specifically, dependency on key negative regulators Wnt-signaling ( Figure 5E ) such as AXIN1 (FDR = 0.00156), GSK3B (FDR = 0.00701) and APC (FDR = 0.133) was increased in melanoma cell lines with low MITF expression levels (Zhan et al., 2017) . Since MITF expression is known to be controlled in part by canonical Wnt signaling (Larue and Delmas, 2006) , this indicates that destruction complex activity might be required to maintain low levels of MITF expression and altered CRC activity. 
DISCUSSION
Over the last years large scale efforts have systematically mapped out the essential genome of hundreds of cancer cell lines (Behan et al., 2018; Hart et al., 2015; Meyers et al., 2017; Tsherniak et al., 2017) . These studies showed that the majority of essential genes are specific to only a subset of these lines. While some of these context-dependent essential genes could be linked to the presence of certain biomarkers, such as for example somatic mutations in onco-or tumor suppressor genes, the mechanisms that impose selective dependencies remain unknown in most cases. Interestingly, similar context-specificity has been observed for the presence of somatic alterations in cancer driver genes (Haigis et al., 2019) . . In cancer, CRC activity is dysregulated as the consequence of alterations in upstream signaling pathways or the CRC TFs themselves. This leads to lineage-specific dependency on genes involved in these processes (red border). Depending on CRC composition, the extent to which each pathway contributes to its activity varies. This could explain why most driver alterations themselves are, to some degree, lineage-specific. CRCs control the activity of various biological mechanisms including both general processes (e.g. the cell cycle) and lineage-specific processes that are responsible for the establishment of cell type-specific phenotypes (e.g. melanogenesis in melanocytes). Many genes involved in general processes, that are often required for tumorigenesis, are found to be broadly essential. However, exceptions exist where genes involved in such processes are essential only in certain lineages. In contrast, dependency on genes involved in establishing lineage-specific cell phenotypes is rarely observed in cell lines.
In this study we integrated genetic dependencies in cancer cells with genomic and transcriptomic data to pinpoint lineage-specific core-regulatory circuits ( processes that regulate CRC activity as well as key CRC target genes ( Figure 6A ) (Bradner et al., 2017) . We demonstrate how these effects can be exploited to systematically predict CRCs and associated biological processes. We provide lists of predicted CRCs and related pathways for 20 different tumor types as a resource for future study. We propose to use these results as starting points for more in depth characterization of the transcriptional mechanisms that lead to dysregulated CRCs in various cancer types. We further envision, that our results will guide the interpretation of new gene essentiality screens in previously uncharacterized cell lines.
We noticed considerable variation regarding TF dependency in cell lines derived from the same cancer lineages.
As an example, we analyze the loss of MITF dependency that co-occurs with the loss of MITF expression in melanoma cells -a phenomenon termed 'phenotype switching' (Li et al., 2015) . Our findings indicate that these cells might alter their CRC through changes in signaling pathway activity -perhaps in order to adapt to a change in environment -creating a new set of vulnerabilities. Similar observations have recently been made in Neuroblastoma. There it was shown that two phenotypically distinct differentiation states exist in these tumors that are controlled by different regulatory circuits (van Groningen et al., 2017) . This could point to a more general phenomenon where the differentiation state of a tumor cell might affect the set of expressed TFs in a tumor cells which consequently could influence CRC composition. This might also explain the varying number of lineage dependency TFs that we identify for each cancer type. For lung cancer, for example, we found only few TF that showed significant lineage dependency although data from a large number of cell lines was available for this tumor type. In our study we simply stratified cancer cell lines by their tissue of origin. However, it is well known that lung cancers are phenotypically diverse and that these phenotypes are associated with differences in gene expression and response to therapy. It has further been shown that lung adenocarcinomas can adapt their regulatory architecture as they progress by suppressing the core TF NKX2-1 (Winslow et al., 2011) . Since lung cancer cell lines do in fact represent tumors of various phenotypes, we assume that a potential reason for the low number of identified LD-TFs could lie in the way we stratified the cell lines. We thus assume that tissues that are composed of many heterogeneous cell types (controlled by different CRCs) that can each give rise to tumor cells then these might be better examined separately.
In conclusion, our analysis provides the first systematic discovery of CRCs that control the transcriptomic states in different cancer lineages. Specifically, we provide insight into their composition, mechanisms by which they are regulated and their plasticity. Our results confirm that transcriptional addiction is a key driver of selective gene dependency in cancer cells and we show that this effect can be exploited to infer regulatory circuits independent of transcriptomic data. As a platform for future studies we provide a list of predicted CRCs and associated biological processes.
In the future we envision that large-scale single-cell sequencing efforts to map different cell types in the human body (Rozenblatt-Rosen et al., 2017) will provide markers for improved stratification of cell lineages that can give rise to cancer. This might then allow to increase the resolution at which CRCs can be discovered in heterogeneous tissues.
Further, CRC TFs are generally characterized by their association with super enhancer elements (Whyte et al., 2013) . Super enhancers are usually identified through ChIP-sequencing of H3K27Ac associated genomic regions (Durbin et al., 2018) . However, these data exist only for a limited number of cell lines. Additionally, CRC studies might benefit from functional screens with image-based phenotyping where morphological changes upon CRC TF perturbation could be observed. This might provide new insights into the mechanisms by which CRC composition influences cell differentiation.
METHODS
Context-specific gene dependencies
To determine context-specific gene dependencies, Avana CRISPR fitness screens were downloaded from the Cancer Dependency Map (DepMap) portal (Supplementary Table 3 ). A two component Gaussian mixture model was then fit to the CERES scores (Meyers et al., 2017 ) measured across all 558 cancer cell lines for each gene in the CRISPR library using the 'mixtools' R package (Benaglia et al., 2009) . Each data point was assigned to one of the mixture components by their posterior probability and the component representing the majority of data was selected as the baseline phenotype distribution of a gene. This is based on the assumption that a particular gene knockout has a similar effect on the majority of cell lines while only a smaller subset of cell lines are especially vulnerable (context-dependent) or resistant to that knockout (Costanzo et al., 2010 (Costanzo et al., , 2016 . For a few genes (78 out of 17,634) a two component mixture could not be fit successfully due to high uniformity of knockout phenotypes across cell lines. These were excluded from downstream analyses.
Also, the gene SOX9 was excluded due to known off-target effects of sgRNAs in the Avana library (Fortin et al., 2019) . Next, a p-value was computed for each knockout phenotype in each gene representing the probability of having observed that phenotype under the baseline phenotype distribution of that gene. Specifically, we tested the null hypothesis where is the mean of the baseline phenotype distribution for gene (as H 0 : μ g = y cg μ g g determined above) and is the CERES score measured in cell line upon knockout of y cg c gene . Resulting p-values were adjusted for multiple testing using the Benjamini-Hochberg g method and context-dependent vulnerabilities were determined at 20% false discovery rate (FDR). Gene set enrichment analysis was performed on all genes ranked by the number of context-dependent cell lines using the 'fgsea' R/Bioconductor (Gentleman et al., 2004; Huber et al., 2015; Sergushichev, 2016) package on Gene Ontology (Gene Ontology Consortium, 2015) Molecular Function gene sets of size 15-500 using 100,000 permutations. GO terms and annotations were downloaded through the 'GO.db' and 'Organism.dplyr' R/Bioconductor packages. Transcription factor (TF) status was assigned for each gene according to Lambert et al (Lambert et al., 2018) . For clustering of cell lines by context-specific TF genes, TF for which context-dependency was determined in more than 25 different cancer cell lines were selected and CERES scores for each TF were centered by subtracting the mean of their baseline phenotype distribution . μ g
Calculation of lineage dependency scores (LD-scores)
For LD-score calculation, all cancer lineages for which CRISPR screening data in more than for multiple testing using the Benjamini-Hochberg method. TP53 mutation status was determined for each cell line according to Cancer Cell Line Encyclopedia and DepMap cell line mutation data (Barretina et al., 2012) . TP53 mutations were considered if they were flagged as either 'isDeleterious' or 'isTCGAhotspot' in the DepMap data set. Silent mutations were excluded. It has been shown that a cell line's TP53 mutation status has a major impact on its gene essentiality profile independent of the cell line's tissue of origin (Rauscher et al., 2018; Tsherniak et al., 2017) . Therefore, we decided to account for TP53 mutations when calculating LD-scores.
Assembly of putative core-regulatory circuits
First, significant lineage dependency TFs were selected (LD-score > 1, FDR < 0.05). To avoid false positives due to potential CRISPR off-target effects, candidate LD-TF not expressed in their associated cancer lineage (median TPM across cell lines of corresponding lineage < 0.1) or reported as loss-of-function tolerant in ExAC (LOF Z-score < 1) were excluded from downstream analyses. Both thresholds were informed by manual examination of known non-expressed/non-essential genes. To determine whether TF target gene-relationships occur at increased frequency between TF that act in the same CRCs, TF-target gene annotations were downloaded from the Harmonizome portal (Rouillard et al., 2016) . Specifically, we downloaded the CHEA, ENCODE, ESCAPE and manually curated TRANSFAC annotation lists (ENCODE Project Consortium, 2004; Lachmann et al., 2010; Matys et al., 2003; Xu et al., 2013) . For each cancer lineage we then counted the number of unique relationships between pairs of significant LD-TFs reported in the above data sets. To understand whether the number of relationships observed between the LD-TFs associated with a cancer lineage was higher than expected by chance, we randomly sampled TFs included in the Harmonizome data and calculated the number of relationships reported between these to infer a null distribution. A Kolmogorov-Smirnov test was then used to compute the probability of having observed the number of regulatory relationships between LD-TFs genes by chance. To test whether LD-TFs are frequently linked to super enhancer (SE) elements in their associated lineages, SE data were downloaded from SEdb (Jiang et al., 2018) for all samples that could be matched to one of the lineages represented by the CRISPR data. Supplementary Table 3 contains SEdb identifiers for samples used for analysis. Each SE element was linked to its closest active gene on the genome as defined by SEdb. Processed HCT116 ChIP-seq peaks were downloaded for H3K27ac, POLR2A and TCF7L2 targets from ENCODE (ENCODE Project Consortium, 2004) .
Molecular characterization of lineage dependency transcription factors
First, genes were divided into significant lineage dependency (LD) TF (LD-score > 1 and FDR < 5%), other TF and non-TF genes. Functional gene constraint scores were downloaded for non-cancer samples from ExAC (Supplementary Table 3 ) (Lek et al., 2016) .
Between the above gene groups, we compared (i) 'LOF Z-scores' which quantify whether a damaging mutation in a gene is observed more or less frequently than expected by chance and (ii) 'pLI scores' scores, which represent the probability of a gene being loss-of-function is the average expression of the gene in log(FPKM+1) in tumor samples and is (T ) μ (H) μ the average expression in healthy samples. A similar analysis was performed for 1,000 equally large sets of randomly selected genes to infer a distribution that indicates how often up-or down-regulation would be expected by chance.
To determine whether LD-TFs are affected by somatic alterations in patient cancer samples, mutation, copy number alteration, methylation and gene fusion data were downloaded from the COSMIC database (Supplementary Table 3 ) (Forbes et al., 2017) .
Silent mutations were excluded. Additionally, gene fusions, copy number gains and hypomethylation events were selected for each sample as reported by COSMIC. If a specific type of variant was observed for a gene in more than 5% of all samples from a certain tumor type, that gene was considered as frequently altered. A Fisher's exact test was performed to determine whether alterations in LD-TF occur more frequently compared to other genes.
Codependency analysis of lineage dependency genes
Lineage dependency scores were calculated for all non-transcription factor genes as described above. Next, significant LD-genes were selected for each cancer lineage (LD-score > 1, FDR < 5%). Genes were excluded if their median expression in cell lines of their associated tissues was below 0.01 (TPM). Gene codependency was then calculated for all possible gene pairs as the Pearson correlation coefficient of their CERES scores across all 558 cell lines in the DepMap data set. LD-genes were clustered into groups according to their codependency using a model based clustering approach implemented in the R package 'mclust'. Here, Gaussian mixture models with up to 10 components (potential clusters) are fitted to the data and the ideal number of clusters is selected according to the Bayesian Information Criterion (BIC) for each model. The maximal number of clusters selected for any lineage was 9 indicating that allowing for up to 10 clusters was appropriate. Next, gene-set enrichment analysis was performed to identify significantly overrepresented Gene Ontology (Gene Ontology Consortium, 2015) Biological Process terms for each cluster. To this end, the methods 'goana' and 'topGO' implemented in the 'limma' R/Bioconductor package were used (Alexa and Rahnenfuhrer, 2010; Ritchie et al., 2015) .
MITF-dependency in melanoma
Normalized gene expression data for melanoma patient samples were downloaded from TCGA using the Rtcga R/Bioconductor package (367 samples) (Huber et al., 2015; Kosinski et al., 2016) . Differentially expressed genes between MITF high and MITF low samples were determined as the degree of coexpression between MITF and all other genes using the The Benjamini-Hochberg method was used to control the false discovery rate (FDR) at 1%.
MITF
codependency in melanoma cancer cell lines (34 cell lines) was determined in a similar manner using CRISPR knockout phenotypes (CERES scores) instead of gene expression values. T-distributed stochastic neighbor embedding (t-SNE; as implemented in the 'Rtsne' R-package) was performed to cluster tumor samples based on gene expression of significant (LD-score > 1, FDR < 5%) lineage dependency transcription factors.
Data and Software Availability
Computer code to reproduce all figures in the manuscript is available online at:
https://github.com/boutroslab/Supplemental-Material/tree/master/Rauscher_2019.
